主要论文 |
1. Hu H, Liu JM, Hu Z, Jiang X, Yang X, Li J, Zhang Y, Yu H*, Khaitovich P. (2018). Recently evolved tumor suppressor transcript TP73-AS1 functions as sponge of human-specific miR-941. Molecular Biology and Evolution 35(5):1063-1077. 2. Dong Yilong, Wang YM, Yang HJ, Yang XZ, Yu HJ. Phytoestrogen a-Zearalanol exerts Anti-Apoptotic Effects in Differentiated PC12 Cells via Estrogen Receptor α. (2015). Basic and Clinical Pharmacology & Toxicology 116(2): 110–114. doi: 10.1111/bcpt.12296. 3.Hu HY, He L, Fominykh K, Yan Z, Guo S, Zhang X, Taylor MS, Tang L, Li J, Liu J, Wang W, Yu H*, Khaitovich P*. (2012). Evolution of the human-specific microRNA miR-941. Nature Communications 3:1145 DOI: 10.1038/ncomms2146. 4.Yu H, Fang L, Li X, Zhang X, Ye J, Li J, Hu W, Zheng B, Xiao C. The evolutionary characteristics of exons expressed at different abundance levels in mammals. (2009). Chinese Science Bulletin 54(19): 3547-3554. 5.Yu H, Jiang H, Zhou Q, Yang J , Cun Y, Su B, Xiao C , Wang W. Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. (2006).Human Molecular Genetics 15(11):1870-1875. 6.Yu H, Zhao X, Su B, Li D, Xu Y, Luo S, Xiao C, Wang W. Expression of NF1 pseudogenes. (2005). Human Mutation 26(5):487-488. 7. Wang W*, Zheng H*, Yang S*, Yu H* (*equal contribution), Li J, Jiang H, Su J, Yang L, Zhang J, McDermott J, Samudrala R, Wang J, Yang H, Yu J, Kristiansen K, Wong GK, Wang J. Origin and evolution of new exons in rodents. (2005). Genome Research 15(9):1258-1264. 8.Du Z, Park KW, Yu H, Fan Q, Li L. Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. (2008) Nature Genetics 40(4):460-465. 9.Li X, Liang J, Yu H, Su B, Xiao C, Shang Y, Wang W. Functional consequences of new exon acquisition in mammalian chromodomain Y-like (CDYL) genes. (2007) . Trends in Genetics 23(9):427-431. 10.Wang W, Yu H, Long M. Duplication-degeneration as a mechanism of gene fission and the origin of new gene is Drosophila species. (2004). Nature Genetics 36(5):523-527. |